(MedPage Today) — The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced Parkinson’s disease, Supernus Pharmaceuticals announced on Tuesday.
The wearable device is the first…
Source link : https://www.medpagetoday.com/neurology/parkinsonsdisease/114074
Author :
Publish date : 2025-02-04 20:19:37
Copyright for syndicated content belongs to the linked Source.
